Resource Logo
AIDS Treatment News

California: New Drugs Added to AIDS Drug Assistance Program




 

AIDS TREATMENT NEWS Issue #223, May 19, 1995

In March 1995, 18 new drugs were added to the California AIDS Drug Assistance Program; these are in addition to the 25 drugs already there. These drugs can be fully or partially reimbursed for persons with HIV with moderate incomes. Funding is from the Federal Ryan White Title II program.

The following drugs are now in the program (the asterisk indicates the new additions): acyclovir, alpha interferon*, amphotericin B, atovaquone, azithromycin, bleomycin sulfate*, clarithromycin, clindamycin, clofazimine, clotrimazole, cyclophosphamide*, dapsone, ddC, ddI, dexamethasone*, doxorubicin*, dronabinol*, epoetin alfa*, ethambutol, filgrastim*, fluconazole, flucytosine, foscarnet, ganciclovir, itraconazole*, ketoconazole, leucovorin calcium*, megestrol acetate*, methotrexate*, nystatin, paromomycin, pentamidine, prednisone*, pyrimethamine, rifabutin, stavudine*, sulfadiazine, trimethoprim*, trimethoprim-sulfamethoxazole, trimetrexate glucuronate*, vinblastine sulfate*, vincristine sulfate*, zidovudine (AZT). Note: The new oral ganciclovir has also been added to the formulary.

Comment New drugs could be added at this time because of reduced expenditures for AZT, often due to the widespread discouragement about treatment caused by misinterpretation of the European Concorde study, which was published in April 1993. That study legitimately raised doubt about certain early uses of AZT, but was widely misunderstood as meaning that HIV treatment did not work.



 


Copyright © 1995 -AIDS Treatment News, Publisher. All rights reserved to AIDS Treatment News (ATN), Email AIDS Treatment News .

Information in this article was accurate in May 19, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.